- This event has passed.
February Research Updates: Combination of urinary PDG/Progesterone and LH urine testing and mobile technology for monitoring of ovulation: potential new approach?”
February 9 @ 8:00 PM - 9:00 PM GMT
- Explore the combination of PDG/Progesterone and LH urine testing for the dynamic monitoring of the menstrual cycle
- Explain the use of e-technology for complementing the menstrual cycle charting
Approved for 1.0 live, virtual AAFP prescribed credit. [1.0 CME credit]*
Webinars are free for all IIRRM members.
Not a member? Join or renew your membership here.
1. Leiva, Rene & McNamara-Kilian, Marie & Niezgoda, Helen & Ecochard, Rene & Bouchard, Thomas. (2019). Pilot observational prospective cohort study on the use of a novel home-based urinary pregnanediol 3-glucuronide (PDG) test to confirm ovulation when used as adjunct to fertility awareness methods (FAMs) stage 1. BMJ Open. 9. e028496. 10.1136/bmjopen-2018- 028496.
2. Leiva RA, Bouchard TP, Abdullah SH, Ecochard R. Urinary Luteinizing Hormone Tests: Which Concentration Threshold Best Predicts Ovulation? [published correction appears in Front Public Health. 2018 Nov 30;6:345]. Front Public Health. 2017;5:320. Published 2017 Nov 28. doi:10.3389/fpubh.2017.00320
Dr. Rene Leiva
Rene Leiva (MD CM, CCFP, FCFP) is a physician and researcher based in Ottawa, Ontario, Canada. Dr. Rene Leiva obtained his medical degree from McGill University and is an Assistant Professor with the University of Ottawa, Department of Family Medicine. One of his main focuses of interest is modern methods of Fertility Awareness Methods and their impact on family planning and infertility. He has published several peer-reviewed research articles.
Continuing Medical Education Accreditation and Credit Statement: